Mounjaro is prescribed for adults who need dual GIP and GLP-1 receptor activity for glycemic control, and research has extended to its weight management outcomes as well
Although the primary outcome occurred in 10.5% of the empagliflozin group versus 12.1% of the placebo group, a difference that was statistically significant, differences between groups for both fatal and nonfatal MI and stroke were not significantly different
Consult with your veterinarian to determine the best approach for your dog's individual needs
Although the current studies on KD and PD show some promising results, there are fewer intervention studies in PD populations, relatively short treatment durations in those with small sample sizes, and the lack of PD-specific outcomes that do exist
Your doctor can tell you which symptoms to watch for and explain which might be a sign that the combination isnt working as planned
SNP rs2071475 is strongly associated with RA and exhibits opposing effects in CD and UC